Allergy/Imm Medical News about immunotherapy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives
Clinical and Experimental Allergy, 09/05/08

Purohit A et al. - Single courses of injection immunotherapy with Bet v 1 allergen derivatives showed trends towards improved well-being and reduced reactivity to specific allergen provocation, but did not yield significant improvement in the combined symptom medication score in this study.

<< Previous
Functional skewing of the global CD8 T cell population in chronic...

Next >>
Reduced rate of adverse reactions to the BCG vaccine in children...